|
Dr. Kawahara has more than 15 years of biotechnology industry experience, including the negotiation of in-licensing agreements, research collaborations, and pharmaceutical partnerships. Prior to joining Receptor BioLogix, he was senior director of business development at Anesiva, Inc., a biopharmaceutical company developing drugs for treating pain and inflammation. Before that, he was director of corporate development at GeneTrol Biotherapeutics, a developer of therapeutic proteins for the treatment of cancer, viral infections and autoimmune diseases. Previously, he was a member of the founding management team and corporate director of planning and business development for Xenogen Corp., and held positions of increasing responsibility at Becton Dickinson and Co. Dr. Kawahara was also director of research at Children’s Hospital Orange County, and a post-doctoral fellow at UCLA. He holds a bachelor’s degree in biology from UCSD, an M.B.A. in finance from CSU, Long Beach, and a Ph.D. in immunology from the University of Rochester. | 